The dose calendar gives you an at-a-glance view of exactly when you last injected, making it easy to determine whether youre still within the catch-up window or need to skip
1987 Jul;34(1):1-24
On portfolio, companies should candidly assess which products face structural headwinds and which are positioned to benefit
DPP-4 inhibitors The DPP-4 inhibitors mediate their action by inhibiting the enzyme DPP-4, which prevents the breakdown of GLP-1 and thereby increases endogenous GLP-1 levels
Review Medical Risks Kidney or liver disease, fluid restrictions, heart failure, pregnancy, allergy history, prior infusion reactions, vein access, and current cancer treatment can change the risk-benefit assessment
They are also sometimes used for sedation during a procedure